BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21676377)

  • 1. New antimicrobial therapies used against fungi present in subgingival sites--a brief review.
    Sardi JC; Almeida AM; Mendes Giannini MJ
    Arch Oral Biol; 2011 Oct; 56(10):951-9. PubMed ID: 21676377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
    Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Staphylococcus spp and Candida spp in the oral cavity and periodontal pockets of periodontal disease patients.
    Cuesta AI; Jewtuchowicz V; Brusca MI; Nastri ML; Rosa AC
    Acta Odontol Latinoam; 2010; 23(1):20-6. PubMed ID: 20645638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local antimicrobial therapies in periodontal disease.
    Kinane DF
    Ann R Australas Coll Dent Surg; 2000 Oct; 15():57-60. PubMed ID: 11709978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy.
    Rodrigues RM; Gonçalves C; Souto R; Feres-Filho EJ; Uzeda M; Colombo AP
    J Clin Periodontol; 2004 Jun; 31(6):420-7. PubMed ID: 15142209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of candida and periodontal disease in immunocompetent and HIV-infected subjects.
    Feller L; Buskin A; Blignaut E
    SADJ; 2005 May; 60(4):152-4. PubMed ID: 15974431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological evaluation of the effects of hyperbaric oxygen on periodontal disease.
    Signoretto C; Bianchi F; Burlacchini G; Canepari P
    New Microbiol; 2007 Oct; 30(4):431-7. PubMed ID: 18080679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida spp. in periodontal disease: a brief review.
    Sardi JC; Duque C; Mariano FS; Peixoto IT; Höfling JF; Gonçalves RB
    J Oral Sci; 2010 Jun; 52(2):177-85. PubMed ID: 20587940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activity of miconazole against recent Candida strains.
    Isham N; Ghannoum MA
    Mycoses; 2010 Sep; 53(5):434-7. PubMed ID: 19531099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy. A viable periodontal treatment modality?
    Deasy MJ
    Dent Clin North Am; 1990 Jan; 34(1):1-11. PubMed ID: 2403938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida biofilms: antifungal resistance and emerging therapeutic options.
    Kuhn DM; Ghannoum MA
    Curr Opin Investig Drugs; 2004 Feb; 5(2):186-97. PubMed ID: 15043393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvovaginal candidiasis in a Flemish patient population.
    De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
    Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of oral candidosis].
    Richardson R; Antilla VJ
    Duodecim; 2010; 126(2):174-80. PubMed ID: 20405603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nystatin and chlorhexidine in oral medicine: Properties, indications and pitfalls with focus on geriatric patients.
    Scheibler E; Garcia MCR; Medina da Silva R; Figueiredo MA; Salum FG; Cherubini K
    Gerodontology; 2017 Sep; 34(3):291-298. PubMed ID: 28556195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological advances in the treatment of invasive candidiasis.
    Deck DH; Guglielmo BJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):137-49. PubMed ID: 16441215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subgingival distribution of yeast and their antifungal susceptibility in immunocompetent subjects with and without dental devices.
    Jewtuchowicz VM; Brusca MI; Mujica MT; Gliosca LA; Finquelievich JL; Lovannitti CA; Rosa AC
    Acta Odontol Latinoam; 2007; 20(1):17-22. PubMed ID: 18046966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.